Golden Synergy Against Metabolic Syndrome: Rice Bran and Turmeric Tablet as a Next-Generation Nutraceutical

Abstract

The collection of related metabolic illnesses known as metabolic syndrome (MetS), which includes obesity, insulin resistance, dyslipidemia, and hypertension, raises the risk of cardiovascular diseases and type 2 diabetes. Metabolic syndrome affects about 25% of the adult population worldwide, making it a significant public health problem. Its prevalence is increasing. The main treatment strategies are still lifestyle changes and pharmacotherapy, but a rising interest in preventive tactics has brought attention to the promise of nutraceuticals as a secure and efficient alternative. By regulating metabolic pathways, lowering oxidative stress, and enhancing lipid and glucose homeostasis, nutraceuticals, which are made from natural dietary components, provide a variety of health benefits. Rice bran, which is high in bioactive chemicals including oryzanol and tocotrienols, has shown considerable promise in controlling lipid metabolism, acting as an antioxidant, and boosting insulin sensitivity. In a similar vein, turmeric, with curcumin as its main bioactive ingredient, has metabolic regulatory, antioxidant, and anti-inflammatory properties, making it a desirable option for treating metabolic diseases. Rice bran and turmeric are combined in a single pill, representing a novel, next-generation nutraceutical strategy that takes advantage of the synergistic benefits of these bioactive to treat several aspects of metabolic syndrome at the same time. A tablet containing rice bran and turmeric may have benefits such as increased bioavailability, greater effectiveness, and convenient oral administration. However, there are still issues to be resolved, such as the low bioavailability of curcumin, the standardization of rice bran extracts, and the need for high-quality clinical trials. Novel approaches, such as nanotechnology-based delivery systems, encapsulation, and sustainable extraction methods, are future directions that aim to improve therapeutic results. Overall, this synergistic combination has the potential to be a natural, safe, and effective intervention for the prevention and treatment of metabolic syndrome, bridging the gap. the distance between nutritional supplementation and clinical advantages, while simultaneously laying the groundwork for future R&D and business innovation in the nutraceutical industry.

Keywords

Metabolic Syndrome, Rice Bran, Turmeric, Curcumin, ?-Oryzanol, Tocotrienols, Nutraceuticals, Synergistic Formulation

Introduction

The pathophysiology of Metabolic Syndrome (MetS) involves a complex interaction between genetic, environmental, and metabolic factors that disrupt normal energy homeostasis. Central to this condition is insulin resistance, which impairs glucose uptake and promotes compensatory hyperinsulinemia, leading to altered lipid metabolism and hypertension.^[14] Visceral adipose tissue acts as an active endocrine organ, secreting pro-inflammatory such as TNF-α, IL-6, and resistin, which further aggravate oxidative stress and vascular dysfunction. These processes contribute to endothelial injury, atherogenesis, and chronic low-grade inflammation, forming a link between MetS and cardiovascular diseases. Moreover, dysregulation of adipokines like adiponectin and leptin plays a crucial role in metabolic imbalance. The convergence of these molecular and physiological disturbances underlies the systemic nature of MetS and emphasizes the importance of targeting multiple pathways for effective management.^[15]

Insulin Resistance:

The metabolic syndrome is a collection of illnesses that raise the risk of diabetes, heart disease, and stroke. It is typified by hypertension, dyslipidemia, obesity, and insulin resistance. When the body’s cells lose their sensitivity to insulin, blood glucose levels rise, leading to insulin resistance, a key component of metabolic syndrome. Insulin resistance and metabolic syndrome are caused by complex interactions between metabolic, environmental, and genetic variables. Adipose tissue function disturbance is one of the primary ways. An important factor in the development of insulin resistance is adipose tissue, especially visceral fat. It causes a number of cytokines and adipokines to be released, which can cause inflammation and lead to insulin resistance and metabolic syndrome.

Dyslipidemia:

Unusual blood lipid levels, such as elevated triglycerides, decreased HDL cholesterol, and occasionally elevated LDL cholesterol, are the hallmarks of dyslipidemia, a crucial component of metabolic syndrome. The complex interplay of metabolic, environmental, and hereditary factors influences dyslipidemia in metabolic syndrome. The main cause of dyslipidemia in metabolic syndrome is insulin resistance, which is a defining feature of the condition. Increased lipolysis and the release of free fatty acids into the bloodstream are the results of insulin resistance’s interference with the normal function of insulin in adipose tissue, which impacts lipid metabolism. This mechanism leads to hypertriglyceridemia by causing the liver to produce too much very low-density lipoprotein (VLDL).^[16]

Chronic Inflammation:

The pro-inflammatory state that results from the several pathogenic mechanisms that lead to the development of MetS accounts for the increase in inflammatory markers such TNFα, C-reactive protein (CRP), and IL-6 that is observed in people with MetS. As previously stated, systemic oxidant stress brought on by insulin resistance and obesity triggers downstream inflammatory cascades that result in tissue fibrosis, atherogenesis, and ultimately CVDs.^[17]

Role of dietary antioxidant and anti-inflammatory :

By successfully regulating important metabolic parameters like blood pressure, blood glucose levels, dyslipidemia, obesity, cholesterol, and triglycerides, the dietary supplements have shown the capacity to lessen early growth limitation and prevent fat buildup. They have also been linked to improvements in coronary artery resistance, improving inflammatory fatty liver diseases including steatohepatitis, lowering oxidative stress, improving insulin resistance, and having anti-inflammatory and antioxidant properties. Nutrients, garlic, and vegetable and animal oils stand out among these supplements. Although there have been conflicting results about the efficacy of dietary supplements for metabolic syndrome, an observational study produced conflicting data. It revealed that there was no discernible difference between the two groups under study in terms of BMI, blood pressure, weight, waist circumference, cholesterol, or serum glucose levels.^[18]

Rice Bran: Composition and Therapeutic Potential

The portion of rice that is removed during the dehusking and milling process, which turns rough rice into polished rice, is known as rice bran. It describes the brownish outer covering of rice grains, which includes the seed coat, endosperm, bran, aleurone, and outer husk. It usually makes up around 8% of the weight of the rice grain and is also referred to as “rice husk” or “rice bran.”  Broken rice and rice germ are frequently found in rice bran, a byproduct of the rice milling process.  Additionally, the accuracy of polished rice and the kind of rice can have a big impact on the composition of rice bran. Typically, 34–62% carbs, 11–15% protein, 15–20% fat, 7–11% dietary fiber, and 8–12% ash make up ordinary rice bran. Furthermore, a number of bioactive substances are present, including ceramides, octacosanol, oryzanol, octacosanol, α-lipoic acid, squalene, tocopherols, tocotrienols, phenolic acids, and flavonoids.^[19]

Figure 2: Rice Bran

Rice bran’s plant sterols may help treat alopecia, hypercholesterolemia (high cholesterol), diabetes (for which a patent has been granted), hepatitis C, herpes, allergies, chronic fatigue, tuberculosis, and breast cancer (hair loss). According to a recent study, eating plant sterols was found to reduce LDL (the bad) cholesterol levels by 20%. Plant sterols have been shown to mitigate the side effects of chemotherapeutic cancer treatments, strengthen the immune system, and combat bacterial infections. The presence of antimicrobials, antioxidants, and numerous other bioactivities is what causes all of these therapeutic effects. The bioactivity of different bioactive rice bran chemicals that may help prevent disease and reduce malnutrition is summarized.

Antioxidant Potential:

Oxidative damage is known to inactivate natural by-products of oxidative metabolism, also known as free radicals, at the cellular and molecular levels. The antioxidant properties of micro compounds of RB, such as phytosterols, γ-oryzanol, and various phytosterol conjugates, have been studied. In both normal and pathological conditions, reactive oxygen species (ROS) lead to the formation of oxidative damage. ROS has been linked to a variety of metabolic diseases, including cardiovascular disease, cataracts, age-related macular degeneration, cancer, and neurological issues.

Antidiabetic Potential:

Poor dietary systems are mostly responsible for excess blood glucose, which can result in dangerous health conditions including diabetes and hyperglycemia. Rice bran and other plant-based foods with a higher dietary fiber content and less free sugar may help maintain a low glycemic index and avoid a number of diseases. Soluble fibers can lower postprandial blood glucose levels in both diabetic and non-diabetic patients. The soluble fiber components of RB are used to make nutraceuticals that effectively combat type I and type II diabetes. RB may be crucial in reducing total cholesterol, triglycerides, and blood sugar.

Anti-cancer potential:

One of the leading causes of death worldwide is cancer, which has left many people dead. Since they encourage the growth, angiogenesis, and motility of cancer cells, infections and various forms of inflammation play a significant role in the development of tumors. Therefore, the main objective of cancer treatment is to reduce inflammation. One of the phytonutrient-rich functional dietary constituents linked to human cancer cell inhibition is RB.

Anti-Inflammatory activity:

It has recently been discovered that fermented RB and its extracts are highly effective at lowering inflammation. Bran oil’s tocotrienol lowers the pancreatic inflammatory environment and prevents the growth of tumors. Cycloartenylferulate, the main constituent of γ-oryzanol (-ORY), inhibited the dose-dependent activation of nuclear factor-B (NFB) by lipopolysaccharide (LPS). -ORY and cycloartenylferulate have been shown to decrease inflammation-related genes, including inducible nitric oxide synthase (NOS), cyclooxygenase-2 (COX-2), IL-1, and tumor necrosis factor (TNF).  These results suggest that γ-oryzanol may be helpful in the management of inflammatory diseases.^[20]

Turmeric (Curcuma longa): Composition and Therapeutic Potential

Turmeric, a powdered form of Curcuma longa (C. longa), has several medicinal properties and is commonly referred to as such. Oleoresins, curcuminoid pigments, extracts, and volatile oils are the main secondary components of turmeric that are responsible for its medicinal properties. Curcuma longa, or turmeric, is a popular natural remedy with a variety of pharmacological properties. As far as its biochemical makeup goes, turmeric is composed of 69.4% carbs, 6.3% protein, 5.1% fat, 3.5% minerals, and 13.1% moisture. About 5% of turmeric is made up of essential oils and 5% of curcumin, a key bioactive component. Despite being insoluble in ether and water, curcumin can dissolve in ethanol and other organic solvents. The primary bioactive components of turmeric are curcumin, dimethoxy curcumin, bis-methoxycurcumin, and tetrahydro curcuminoid. Curcumin, the active ingredient, makes up 1.5–2% of turmeric root. It has been observed that turmeric has a variety of curcumin forms, including 77% diferuloylmethane, 18% dimethoxy, 5% bisdemethoxy, and several human routes.^[21]

Figure 3: Turmeric (Curcuma Longa)

Approximately 20% of people worldwide are thought to be affected by MetS. The metabolic components that are hypothesized to make up multiple sclerosis (MS) vary based on factors including sex and ethnicity. All things considered, the following are widely acknowledged: obesity, hypertension, dyslipidemia, and/or impaired glucose tolerance or diabetes. Through the suppression of PPAR and CCAAT/enhancer-binding protein alpha expression, as well as the reduction of cholesterol, curcumin has been demonstrated to play a part in reducing angiogenesis and adipogenesis. Furthermore, curcumin can stimulate insulin production by upregulating the gene expression of GLUT2, GLUT3, and GLUT4 (pancreatic glucose transporter 2).^[22]

Numerous studies have demonstrated that Curcuma longa’s anti-inflammatory, anti-oxidant, anti-microbial, anti-bacterial, anti-viral, anti-fungal, anti-hypoglycemic, anti-obesity, anti-hypertensive, anti-depressant neuroprotective and chemopreventive properties can help treat a number of pathological conditions.^[23]

Obesity, particularly abdominal obesity, is strongly linked to higher cardiovascular disease morbidity and death. In clinical settings, obesity is frequently evaluated using a number of anthropometric measurements, including body weight, hip and waist circumferences, and body mass index (BMI). Additionally, dyslipidemia and dysglycemia, including higher FBG, HbA1c, LDL-C, TG, and TC values, are frequently seen in obese individuals. Cell, tissue, and organ damage results from these anomalies' slow induction of oxidative stress and inflammation. curcumin's impact on obese or overweight individuals anthropometric measurements, inflammation, oxidative stress indicators, dysglycemia, and dyslipidemia.^[24]

Synergistic Mechanisms of Rice Bran + Turmeric Combination:

The combined use of rice bran and turmeric demonstrates multiple complementary and synergistic biochemical effects that extend beyond their individual actions.

Complementary actions:

Rice bran contains abundant bioactive lipids, such as γ-oryzanol, tocotrienols, and arabinoxylan, which possess antioxidant and lipid-lowering properties. These compounds contribute to the reduction of lipid peroxidation and modulation of serum cholesterol levels, thereby supporting cardiovascular and metabolic health. Turmeric, on the other hand, is rich in curcuminoids, particularly curcumin, which exhibits potent anti-inflammatory and insulin-sensitizing effects through inhibition of NF-κB, TNF-α, and IL-6 pathways.^[25]

Turmeric and rice bran target different but connected metabolic pathways to produce complimentary metabolic effects.  In order to lower cardiovascular risk, rice bran’s dietary fibers, oryzanol, and tocotrienols improve lipid profiles, strengthen antioxidant defenses, and promote liver function.  The curcuminoids found in turmeric increase insulin sensitivity, inhibit pro-inflammatory mediators, and alter glucose metabolism.  These bioactives work together to create a multi-targeted strategy that supports vascular health, modulates lipid and glucose homeostasis, and lowers oxidative stress.  It is clear from this complementary interaction that rice bran and turmeric can work together as a nutraceutical strategy to avoid metabolic syndrome.^[26]

Combined effect:

The co-treatment of turmeric extract with black rice bran produced a more pronounced cytotoxic and antioxidant effect compared to either extract alone, indicating a biochemical synergy that reduces oxidative stress and inflammatory responses. Similarly, a combination of arabinoxylan rice bran (MGN-3/Biobran) with curcumin enhanced apoptosis induction and immune modulation in cancer cells. Together, these findings suggest that this combination not only protects cellular integrity but also improves lipid and glucose metabolism by mitigating oxidative and inflammatory insults.^[25]

Rice bran and turmeric work together to target several metabolic pathways at once, providing a complementary and synergistic approach to the treatment of metabolic syndrome (MetS). The γ-oryzanol and tocotrienols in rice bran aid in controlling lipid metabolism and lowering oxidative stress, whereas the curcumin in turmeric alters inflammatory mediators like TNF-α, IL-6, and NF-κB. When combined, these bioactives have stronger anti-inflammatory, antioxidant, and hypolipidemic effects than when taken separately. By enhancing insulin sensitivity, endothelial function, and mitochondrial activity, the synergistic combination helps to optimize glucose consumption and protect the cardiovascular system. Combinations like this show how nutraceutical formulations can potentially affect several biochemical pathways, providing a safe and comprehensive approach to regulating and avoiding metabolic syndrome.^[27]

Potential biochemical synergy:

The interaction between rice bran and turmeric bioactives may enhance bioavailability and cellular uptake. Evidence indicates that curcumin can improve the intestinal absorption and metabolic stability of rice bran constituents, promoting more efficient utilization of γ-oryzanol and tocotrienols. This synergistic mechanism could underlie their observed improvements in oxidative balance, inflammation control, and metabolic regulation when administered together.^[28]

Tablet Formulation Aspects:

Rationale:

The development of a rice bran and turmeric-based oral tablet provides significant advantages in terms of dose precision, stability, and patient compliance. Oral tablets are preferred for nutraceutical delivery because they enable accurate dosing, ease of administration, and extended shelf-life compared to liquid or capsule forms. Moreover, compression of bioactive extracts into solid dosage forms helps protect thermolabile components from degradation during handling and storage. The convenience of oral tablets further enhances adherence in chronic supplementation regimens such as for metabolic syndrome or diabetes.

Formulation considerations:

Natural excipients derived from rice bran serve multiple roles in formulation, including as binders, lubricants, and disintegrants. The excellent lubrication properties of rice bran wax and its compatibility with various active ingredients. Rice bran-based excipients improve tablet hardness, uniformity, and disintegration time, ensuring mechanical integrity without synthetic additives.^[29] For turmeric, the main challenge lies in enhancing the bioavailability of curcumin, a compound with inherently low solubility and rapid metabolism. Strategies such as co-formulation with piperine, or encapsulation using liposomal and nanocarrier systems, have shown to significantly increase curcumin absorption and systemic exposure. Additionally, maintaining stability of bioactives during compression and storage is crucial. Protective excipients, controlled humidity, and proper coating can minimize oxidation and thermal degradation of both rice bran and curcumin components.^[30]

Proposed composition:

A rational formulation could include Rice bran extract (source of γ-oryzanol, tocotrienols, and arabinoxylan) and Curcumin standardized extract (containing 95% curcuminoids) as the core actives. Optionally, Piperine (2–5 mg/tablet) may be incorporated to enhance curcumin bioavailability through inhibition of hepatic and intestinal glucuronidation. Supporting excipients such as rice bran wax, microcrystalline cellulose, or starch can serve as natural binders and lubricants to maintain tablet structure and compressibility.^[31]

Quality Control, Safety, and Standardization Parameters:

Quality Control Parameters:

Quality control (QC) of herbal and nutraceutical tablets ensures product consistency, efficacy, and consumer safety. Evaluation parameters include organoleptic, physicochemical, and performance characteristics. Standard tablet assessments such as weight variation, hardness (4–8 kg/cm²), friability (<1%), disintegration time (<30 minutes), and dissolution profile are routinely performed to ensure batch uniformity and bioavailability. In herbal formulations, moisture content, ash value, and extractive value are also analyzed to verify raw material purity and to detect adulteration or contamination. Analytical techniques like High-Performance Liquid Chromatography (HPLC) and UV–visible spectroscopy are used for quantitative estimation of key actives such as curcumin and γ-oryzanol.^[32]

Safety Evaluation:

Safety assessment is essential for validating the long-term use of rice bran and turmeric-based tablets. Acute and sub-chronic toxicity studies in animals have shown no significant adverse effects on liver, kidney, or hematological parameters, even at higher doses of curcumin or rice bran extract. Turmeric and rice bran constituents exhibit a wide safety margin, with the LD?? exceeding 2 g/kg body weight. Furthermore, clinical data support the non-toxic and well-tolerated nature of turmeric supplementation in humans with metabolic syndrome, diabetes, and cardiovascular conditions.^[33]

Standardization Parameters:

Standardization involves the quantitative and qualitative evaluation of phytoconstituents to guarantee reproducibility and therapeutic consistency. Standardization of rice bran extract is achieved through determination of γ-oryzanol, tocotrienols, and arabinoxylan content, while turmeric extract is standardized based on curcumin concentration (≥95%).^[34]

Market Potential and Commercial Perspectives:

Global Nutraceutical Market Trends for Metabolic Health:

The global nutraceuticals market was valued at USD 591.1 billion in 2024 and is projected to reach USD 919.1 billion by 2030, growing at a CAGR of 7.6% from 2025 to 2030. This growth is attributed to increasing consumer awareness of preventive healthcare and the link between diet and well-being.

Absence of a Combined Rice Bran + Turmeric Product-  Novelty Factor:

While both rice bran and turmeric are individually recognized for their health benefits, there is a notable absence of a combined product that leverages the synergistic effects of these ingredients. The combination of turmeric and black rice bran exhibits greater cytotoxic activity than the individual extracts, suggesting potential for enhanced therapeutic effects.

Potential Positioning: “Natural Metabolic Health Regulator”

Positioning the product as a “Natural Metabolic Health Regulator” aligns with current consumer trends favoring natural and preventive health solutions. This positioning can differentiate the product in a competitive market, appealing to health-conscious consumers seeking natural alternatives to manage metabolic health.^[35]

Challenges and Future Prospects:

The development of a combined rice bran and turmeric tablet faces several challenges that must be addressed to optimize efficacy and marketability.

Curcumin Bioavailability:

 The active component of turmeric, curcumin, has a low oral bioavailability due to its rapid metabolism, systemic elimination, and low solubility. Techniques like co-administration with absorption enhancers like piperine, solid lipid nanoparticles (SLNs), and nanoencapsulation have been studied to improve its bioavailability.^[36]

Standardization of Rice Bran Extract:

Rice bran contains bioactive compounds like γ-oryzanol, tocopherols, and ferulic acid. However, variability in raw material quality and extraction methods complicates standardization. Advanced stabilization techniques, including enzymatic treatments and supercritical fluid extraction, are being investigated to maintain consistent quality.^[37]

Clinical Trials on Combined Formulations:

While individual components have shown promise, there is a lack of clinical trials evaluating the combined formulation of rice bran and turmeric. Preclinical studies suggest potential synergistic effects, but human clinical trials are necessary to confirm efficacy and safety.^[35]

Sustainability and Cost-Effective Extraction:

Traditional extraction methods can be energy-intensive and environmentally harmful. Emerging green extraction techniques, such as microwave-assisted and supercritical fluid extraction, offer sustainable alternatives that reduce solvent use and energy consumption.^[38]

Future Directions:

The integration of nanotechnology for encapsulation, along with green extraction methods, holds promise for enhancing the stability, bioavailability, and sustainability of the combined formulation. Continued research and development in these areas are essential for the successful commercialization of the “Golden Synergy” tablet.

CONCLUSION:

The Rice Bran + Turmeric tablet represents a novel, synergistic, and sustainable approach for addressing the complex metabolic disturbances associated with metabolic syndrome. By combining the bioactive compounds of rice bran, such as γ-oryzanol and tocotrienols, with curcumin from turmeric, this formulation targets multiple pathways involved in lipid metabolism, glucose regulation, oxidative stress, and inflammation. The synergistic interaction of these natural ingredients enhances their overall efficacy, providing a holistic strategy for the prevention and management of metabolic syndrome. Furthermore, this nutraceutical approach aligns with current consumer preferences for natural, safe, and preventive healthcare solutions. Despite its promising potential, challenges such as curcumin’s limited bioavailability, variability in rice bran extract standardization, and the need for robust clinical validation remain. Future research should focus on formulation optimization, including advanced delivery systems such as nanoencapsulation and green extraction methods, to improve stability, bioavailability, and sustainability. With comprehensive clinical trials and regulatory compliance, the Rice Bran + Turmeric tablet could emerge as a next-generation nutraceutical, bridging the gap between traditional dietary supplementation and evidence-based preventive therapy. Overall, this formulation not only offers a natural and effective intervention for metabolic health but also opens avenues for innovative product development in the growing nutraceutical market.

REFERENCES

1. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Therapeutic advances in cardiovascular disease. 2017 Aug;11(8):215-25.
2. Saklayen MG. The global epidemic of the metabolic syndrome. Current hypertension reports. 2018 Feb;20(2):1-8.
3. Samson SL, Garber AJ. Metabolic syndrome. Endocrinology and Metabolism Clinics. 2014 Mar 1;43(1):1-23.
4. Grundy SM. Metabolic syndrome update. Trends in cardiovascular medicine. 2016 May 1;26(4):364-73.
5. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH. The metabolic syndrome. Endocrine reviews. 2008 Dec 1;29(7):777-822.
6. Reaven GM. The metabolic syndrome: time to get off the merry?go?round?. Journal of internal medicine. 2011 Feb;269(2):127-36.
7. Aguilar-Garcia C, Gavino G, Baragaño-Mosqueda M, Hevia P, Gavino VC. Correlation of tocopherol, tocotrienol, γ-oryzanol and total polyphenol content in rice bran with different antioxidant capacity assays. Food Chemistry. 2007 Jan 1;102(4):1228-32.
8. Tantayakhom S, Inpan R, Yaja K, Koonrungsesomboon N, Teekachunhatean S, Na Takuathung M. Effects of Rice Bran Supplementation on Metabolic Syndrome-Related Parameters: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2025 Sep 17;26(18):9051.
9. Azhdari M, Karandish M, Mansoori A. Metabolic benefits of curcumin supplementation in patients with metabolic syndrome: A systematic review and meta?analysis of randomized controlled trials. Phytotherapy research. 2019 May;33(5):1289-301.
10. Trinidad TP, Sagum RS, Leon MD, Mallillin AC, Borlagdan MP. Zingiber officinale and Curcuma longa as potential functional foods/ingredients.
11. Kehinde SA, Qaisrani ZN, Pattanayaiying R, Lin WP, Lay BB, Phyo KY, San MM, Awaeloh N, Aunsorn S, Kitkangplu R, Chusri S. Preclinical Evidence of Curcuma longa Linn. as a Functional Food in the Management of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Rodent Studies. Biomedicines. 2025 Aug 5;13(8):1911.
12. Kaur G, Mukundan S, Wani V, Kumar MS. Nutraceuticals in the management and prevention of metabolic syndrome. Austin J Pharmacol Ther. 2015;3(1):1063.
13. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Therapeutic advances in cardiovascular disease. 2017 Aug;11(8):215-25.
14. Petersen KF, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98(4):2133–223.
15. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Therapeutic advances in cardiovascular disease. 2017 Aug;11(8):215-25.
16. Patial R, Batta I, Thakur M, Sobti RC, Agrawal DK. Etiology, Pathophysiology, and Treatment Strategies in the Prevention and Management of Metabolic Syndrome. J Transl Res Med Sci. 2024 Oct 28
17. Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, Assi HI. Metabolic syndrome: updates on pathophysiology and management in 2021. International journal of molecular sciences. 2022 Jan 12;23(2):786.
18. Abdulghani MF, Al-Fayyadh S. Natural products for managing metabolic syndrome: a scoping review. Frontiers in Pharmacology. 2024 Apr 30;15:1366946.
19. Liu Z, Liu X, Ma Z, Guan T. Phytosterols in rice bran and their health benefits. Frontiers in Nutrition. 2023 Oct 12;10:1287405.
20. Manzoor A, Pandey VK, Dar AH, Fayaz U, Dash KK, Shams R, Ahmad S, Bashir I, Fayaz J, Singh P, Khan SA. Rice bran: Nutritional, phytochemical, and pharmacological profile and its contribution to human health promotion. Food chemistry advances. 2023 Oct 1;2:100296.
21. Abd El-Hack ME, Alazragi R, Khafaga AF, Qadhi A, Ghafouri K, Azhar W, Alqhtani AH, Khojah H, Swelum AA, ?wi?tkiewicz S. The relationship between dietary curcumin supplementation and metabolic syndrome–a review. Annals of Animal Science. 2024 Apr 1;24(2):413-24.
22. Jabczyk M, Nowak J, Hudzik B, Zubelewicz-Szkodzi?ska B. Curcumin in metabolic health and disease. Nutrients. 2021 Dec 11;13(12):4440.
23. Laurindo LF, da Silva MM, de Oliveira JG, Silva JBP. Curcuma longa and curcumin on metabolic syndrome: a review. Longhua Chin Med (LCM). 2021;6:13.
24. Zeng Y, Luo Y, Wang L, Zhang K, Peng J, Fan G. Therapeutic effect of curcumin on metabolic diseases: Evidence from clinical studies. International Journal of Molecular Sciences. 2023 Feb 7;24(4):3323.
25. Silfarohana R, Waskita KN, Mar’ah NH, Rohman MS, Rukmana RM. Investigating the Potential Synergistic Effects of Turmeric Extract and Black Rice Bran as Cytotoxic Agents Against HeLa Cells. Asian Pacific Journal of Cancer Prevention: APJCP. 2025;26(3):1059.
26. Ahmad T, Mishra S, Shukla S. Functional role of rice bran and curcumin in metabolic disorders: a mechanistic review. Phytother Res. 2020;34(10):2441–2455.
27. Ghosh S, Banerjee S, Sil PC. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food and Chemical Toxicology. 2015 Sep 1;83:111-24.
28. Ghoneum M, Gollapudi S. Synergistic apoptotic effect of arabinoxylan rice bran (MGN-3/Biobran) and curcumin (turmeric) on human multiple myeloma cell line U266 in vitro. Neoplasma. 2011 Jan 1;58(2):118.
29. Kittipongpatana OS, Trisopon K, Wattanaarsakit P, Kittipongpatana N. Utilization and evaluation of rice bran and rice bran wax as a tablet lubricant. Pharmaceutics. 2024 Mar 20;16(3):428.
30. Bellad KA, Nanjwade BK, Sarkar AB, Srichana T, Shetake RM. Development and evaluation of curcumin floating tablets. Pharm Anal Acta. 2020;12:622.
31. Pathomwichaiwat T, Jinatongthai P, Prommasut N, Ampornwong K, Rattanavipanon W, Nathisuwan S, Thakkinstian A. Effects of turmeric (Curcuma longa) supplementation on glucose metabolism in diabetes mellitus and metabolic syndrome: An umbrella review and updated meta-analysis. PLoS One. 2023 Jul 20;18(7):e0288997.
32. Singh R, Bharti N, Rai DK. Analytical standardization and quality control of herbal tablets using validated HPLC methods. J Pharm Biomed Anal. 2020;189:113437.
33. Nair A, Jacob S, Al-Dhubiab BE. Toxicological evaluation of herbal formulations containing curcumin and rice bran extract. Regul Toxicol Pharmacol. 2021;125:105005.
34. Patel S, Suleria HAR, Rauf A. Nutraceutical potential and standardization of rice bran and turmeric bioactives: A comprehensive review. Food Rev Int. 2019;35(7):659–78.
35. Silfarohana R, Waskita KN, Mar’ah NH, Rohman MS, Rukmana RM. Investigating the Potential Synergistic Effects of Turmeric Extract and Black Rice Bran as Cytotoxic Agents Against HeLa Cells. Asian Pacific Journal of Cancer Prevention: APJCP. 2025;26(3):1059.
36. Tabanelli R, et al. Improving curcumin bioavailability: Current strategies and future perspectives. Pharmaceutics. 2021;13(10):1715. doi:10.3390/pharmaceutics13101715.
37. Das PP, et al. Rice bran extraction and stabilization methods for nutrient retention. Food Research International. 2024;140:109-117. doi:10.1016/j.foodres.2020.109117.
38. More PR, et al. Green, environment-friendly and sustainable techniques for bioactive extraction. Trends in Food Science & Technology. 2022;118:123-135. Doi:10.1016/j.tifs.2021.11.012.